← Companies|Cellectis
CL

Cellectis

CLLS·NASDAQParis FRFounded 1999300 employees
Small CapbiotechPublicOncology
Platform: TALEN CAR-T
Market Cap
$0.3B
All Drugs
2
Clinical Trials
6
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (CLLS)
Loading CLLS stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
CLL-8422CLL-8422Approved4mAbKRASG12CEZH2iIPFPNH
CLL-5354CLL-5354Preclinical2mAbFcRnPLK4iALLHeart Failure
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2026-06-24
CLL-8422 Ph3 Readout
OCD
Ph3 Readout
2026-11-22
CLL-5354 Interim
Heart Failure
Interim
2029-03-12
CLL-5354 Interim
Heart Failure
Interim
2031-03-20
CLL-8422 Ph3 Readout
OCD
Ph3 Readout
2031-06-26
CLL-8422 Ph3 Readout
IPF
Ph3 Readout